Emosis Diagnostics SAS news
On World Thrombosis Day, October 13, 2021, Emosis is proud to be a "messenger" of the "Eyes open to Thrombosis" information campaign.
Eyes open to ThrombosisWTD is an educational campaign to raise awareness and educate the public to the importance of reducing death and disability from thrombosis. It is a global alliance of thousands of local, regional, national and international organizations and advocates. Through events such as conferences, scientific meeti
EmoCellix will focus on marketing a complete solution for hemostasis and thrombosis cytomolecular diagnostics.
The French innovative Medical Device start-up Emosis, specializing in cytomolecular diagnostics of thrombosis and hemostasis disorders, is reinforcing its intellectual property on HIT Confirm®, Emosis first test kit which was recently launched in Europe
(CE Mark).
The company was granted a US patent “Platelet Analysis System” (US10, 012,658 B2), and the PCT of the patent “Heparin-induced thrombocytopenia test” (PCT/IB2018/052179) was recently published